BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29407328)

  • 1. Outcomes of Controlled Donation After Cardiac Death Compared With Donation After Brain Death in Liver Transplantation: A Systematic Review and Meta-analysis.
    Tang JX; Na N; Li JJ; Fan L; Weng RH; Jiang N
    Transplant Proc; 2018; 50(1):33-41. PubMed ID: 29407328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.
    Taner CB; Bulatao IG; Keaveny AP; Willingham DL; Pungpapong S; Perry DK; Rosser BG; Harnois DM; Aranda-Michel J; Nguyen JH
    Liver Transpl; 2011 Jun; 17(6):641-9. PubMed ID: 21618684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable Outcomes of Liver Transplantation from Controlled Circulatory Death Donors Using Normothermic Regional Perfusion Compared to Brain Death Donors.
    Savier E; Lim C; Rayar M; Orlando F; Boudjema K; Mohkam K; Lesurtel M; Mabrut JY; Pittau G; Begdadi N; Cherqui D; Adam R; Dondero F; Sepulveda A; Soubrane O; Bucur P; Barbier L; Salame E; Jasseron C; Antoine C; Riou B; Scatton O
    Transplantation; 2020 Sep; 104(9):1943-1951. PubMed ID: 32639402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing outcomes of donation after cardiac death versus donation after brain death in liver transplant recipients with hepatitis C: a systematic review and meta-analysis.
    Wells M; Croome KM; Janik T; Hernandez-Alejandro RM; Chandok NM
    Can J Gastroenterol Hepatol; 2014 Feb; 28(2):103-8. PubMed ID: 24288695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation.
    Hessheimer AJ; Coll E; Torres F; Ruíz P; Gastaca M; Rivas JI; Gómez M; Sánchez B; Santoyo J; Ramírez P; Parrilla P; Marín LM; Gómez-Bravo MÁ; García-Valdecasas JC; López-Monclús J; Boscá A; López-Andújar R; Fundora-Suárez J; Villar J; García-Sesma Á; Jiménez C; Rodríguez-Laíz G; Lladó L; Rodríguez JC; Barrera M; Charco R; López-Baena JÁ; Briceño J; Pardo F; Blanco G; Pacheco D; Domínguez-Gil B; Sánchez Turrión V; Fondevila C
    J Hepatol; 2019 Apr; 70(4):658-665. PubMed ID: 30582980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors.
    Taner CB; Bulatao IG; Willingham DL; Perry DK; Sibulesky L; Pungpapong S; Aranda-Michel J; Keaveny AP; Kramer DJ; Nguyen JH
    Liver Transpl; 2012 Jan; 18(1):100-11. PubMed ID: 21837741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined lung and liver procurement in controlled donation after circulatory death using normothermic abdominal perfusion. Initial experience in two Spanish centers.
    Miñambres E; Ruiz P; Ballesteros MA; Álvarez C; Cifrián JM; Atutxa L; Ventoso A; Castillo F; Gastaca M
    Am J Transplant; 2020 Jan; 20(1):231-240. PubMed ID: 31265753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of pancreas transplantation from donation after circulatory death compared to donation after brain death.
    van Loo ES; Krikke C; Hofker HS; Berger SP; Leuvenink HG; Pol RA
    Pancreatology; 2017; 17(1):13-18. PubMed ID: 27838258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes From Pancreatic Transplantation in Donation After Cardiac Death: A Systematic Review and Meta-Analysis.
    Shahrestani S; Webster AC; Lam VW; Yuen L; Ryan B; Pleass HC; Hawthorne WJ
    Transplantation; 2017 Jan; 101(1):122-130. PubMed ID: 26950713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
    Trivedi PJ; Scalera I; Slaney E; Laing RW; Gunson B; Hirschfield GM; Schlegel A; Ferguson J; Muiesan P
    J Hepatol; 2017 Nov; 67(5):957-965. PubMed ID: 28690174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation.
    O'Neill S; Roebuck A; Khoo E; Wigmore SJ; Harrison EM
    Transpl Int; 2014 Nov; 27(11):1159-74. PubMed ID: 25052036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung transplantation from donation after controlled cardiocirculatory death. Systematic review and meta-analysis.
    Palleschi A; Rosso L; Musso V; Rimessi A; Bonitta G; Nosotti M
    Transplant Rev (Orlando); 2020 Jan; 34(1):100513. PubMed ID: 31718887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney transplant outcomes in elderly recipients with controlled donation after circulatory death or donation after brain death donors: a registry cohort study.
    Pérez-Sáez MJ; Juega J; Zapatero A; Comas J; Tort J; Lauzurica R; Pascual J
    Transpl Int; 2021 Dec; 34(12):2507-2514. PubMed ID: 34664327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience.
    Grewal HP; Willingham DL; Nguyen J; Hewitt WR; Taner BC; Cornell D; Rosser BG; Keaveny AP; Aranda-Michel J; Satyanarayana R; Harnois D; Dickson RC; Kramer DJ; Hughes CB
    Liver Transpl; 2009 Sep; 15(9):1028-35. PubMed ID: 19718636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of lung and liver transplantation after simultaneous recovery using abdominal normothermic regional perfusion in donors after the circulatory determination of death versus donors after brain death.
    Campo-Cañaveral de la Cruz JL; Miñambres E; Coll E; Padilla M; Antolín GS; de la Rosa G; Rosado J; González García FJ; Crowley Carrasco S; Sales Badía G; Fieria Costa EM; García Salcedo JA; Mora V; de la Torre C; Badenes R; Atutxa Bizkarguenaga L; Domínguez-Gil B
    Am J Transplant; 2023 Jul; 23(7):996-1008. PubMed ID: 37100392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midterm Results of Renal Transplantation From Controlled Cardiac Death Donors Are Similar to Those From Brain Death Donors.
    Lafuente O; Sánchez-Sobrino B; Pérez M; López-Sánchez P; Janeiro D; Rubio E; Huerta A; Marques M; Llópez-Carratala MR; Rubio JJ; Portolés J
    Transplant Proc; 2016 Nov; 48(9):2862-2866. PubMed ID: 27932093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
    Tao R; Ruppert K; Cruz RJ; Malik SM; Shaikh O; Ahmad J; DiMartini A; Humar A; Fontes PA; de Vera ME
    Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results in liver transplantation using grafts from donors after controlled circulatory death: A single-center experience comparing donor grafts harvested after controlled circulatory death to those harvested after brain death.
    Otero A; Vázquez MA; Suárez F; Pértega S; Rivas JI; Mosteiro F; Gómez M
    Clin Transplant; 2020 Jan; 34(1):e13763. PubMed ID: 31808579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar liver transplantation survival with selected cardiac death donors and brain death donors.
    Dubbeld J; Hoekstra H; Farid W; Ringers J; Porte RJ; Metselaar HJ; Baranski AG; Kazemier G; van den Berg AP; van Hoek B
    Br J Surg; 2010 May; 97(5):744-53. PubMed ID: 20393979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longterm results of liver transplantation from donation after circulatory death.
    Blok JJ; Detry O; Putter H; Rogiers X; Porte RJ; van Hoek B; Pirenne J; Metselaar HJ; Lerut JP; Ysebaert DK; Lucidi V; Troisi RI; Samuel U; den Dulk AC; Ringers J; Braat AE;
    Liver Transpl; 2016 Aug; 22(8):1107-14. PubMed ID: 27028896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.